Literature DB >> 19419817

Type 2 diabetes: Microvascular ischemia of pancreatic islets?

Michael G Tal1.   

Abstract

Hyperglycemia is a key factor in both beta cell death and dysfunction as well as in development of microvascular disease. The hypothesis described in this paper suggests that pancreatic microvascular endothelial dysfunction and subsequent microvascular disease of the pancreas causes islet ischemia. This subtle ischemia is the cause of initial dysfunction and subsequent apoptosis of B cells which is preceding development of type 2 diabetes. Moreover, the subtle beta cell ischemia will continue to diminish the beta cells' ability to secrete the increasing amount of insulin needed as the insulin resistant state progresses into type 2 diabetes. This vicious cycle might perpetuate type 2 diabetes.

Entities:  

Mesh:

Year:  2009        PMID: 19419817     DOI: 10.1016/j.mehy.2009.03.034

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

1.  Associations between hemoglobin concentrations and the clinical characteristics of patients with type 2 diabetes.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

2.  Hypertensive target organ damage predicts incident diabetes mellitus.

Authors:  Raffaele Izzo; Giovanni de Simone; Valentina Trimarco; Eva Gerdts; Renata Giudice; Olga Vaccaro; Nicola De Luca; Bruno Trimarco
Journal:  Eur Heart J       Date:  2013-07-23       Impact factor: 29.983

3.  ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.

Authors:  Paul S de Vries; Thijs T W van Herpt; Symen Ligthart; Albert Hofman; M Arfan Ikram; Mandy van Hoek; Eric J G Sijbrands; Oscar H Franco; Moniek P M de Maat; Frank W G Leebeek; Abbas Dehghan
Journal:  Diabetologia       Date:  2016-10-27       Impact factor: 10.122

4.  Decrease in Pancreatic Perfusion of Patients with Type 2 Diabetes Mellitus Detected by Perfusion Computed Tomography.

Authors:  Tiago Severo Garcia; Jean-Luc Engelholm; Michaël Vouche; Cristiane Bauermann Leitão
Journal:  J Clin Imaging Sci       Date:  2021-09-27

Review 5.  Heart Failure and Pancreas Exocrine Insufficiency: Pathophysiological Mechanisms and Clinical Point of View.

Authors:  Olivier C Dams; Marlene A T Vijver; Charlotte L van Veldhuisen; Robert C Verdonk; Marc G Besselink; Dirk J van Veldhuisen
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

6.  Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of β-cell mass.

Authors:  Judith Agudo; Eduard Ayuso; Veronica Jimenez; Alba Casellas; Cristina Mallol; Ariana Salavert; Sabrina Tafuro; Mercè Obach; Albert Ruzo; Marta Moya; Anna Pujol; Fatima Bosch
Journal:  Diabetes       Date:  2012-09-06       Impact factor: 9.461

7.  Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.

Authors:  Mehran Rahimi; Manlio Vinciguerra; Mojtaba Daghighi; Behiye Özcan; Vishtaseb Akbarkhanzadeh; Fareeba Sheedfar; Marzyeh Amini; Tommaso Mazza; Valerio Pazienza; Mahdi M Motazacker; Morteza Mahmoudi; Felix W M De Rooij; Eric Sijbrands; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Oncotarget       Date:  2015-10-06

8.  Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.

Authors:  Zhen Zhang; Lei Yang; Lei Lei; Rongping Chen; Hong Chen; Hua Zhang
Journal:  Int J Mol Med       Date:  2016-08-19       Impact factor: 4.101

9.  Endothelial Function Assessed by Digital Volume Plethysmography Predicts the Development and Progression of Type 2 Diabetes Mellitus.

Authors:  Omar Hahad; Philipp S Wild; Jürgen H Prochaska; Andreas Schulz; Iris Hermanns; Karl J Lackner; Norbert Pfeiffer; Irene Schmidtmann; Manfred Beutel; Tommaso Gori; John E Deanfield; Thomas Münzel
Journal:  J Am Heart Assoc       Date:  2019-10-04       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.